The chemical class of SRPK1 activators includes a diverse set of compounds that modulate the activity of serine-arginine protein kinase 1, influencing cellular processes related to alternative splicing. SPHINX31, a selective SRPK1 inhibitor, directly targets SRPK1, impacting the phosphorylation of splicing factors and potentially influencing alternative splicing. SRPIN340, another selective inhibitor of SRPK1, directly modulates the activity of SRPK1, affecting its kinase function and influencing splicing factor phosphorylation, thereby contributing to the regulation of alternative splicing. SPHINX29, a selective SRPK1 inhibitor, directly impacts SRPK1, potentially modulating the phosphorylation of splicing factors and contributing to the regulation of alternative splicing. Myricetin, a natural flavonoid, inhibits SRPK1 activity, suggesting a role in modulating splicing factor phosphorylation and influencing alternative splicing.
Tanshinone IIA, a natural product with reported SRPK1 inhibitory activity, may influence splicing factor phosphorylation, contributing to the regulation of alternative splicing. Naphthol AS-E Phosphate, a selective SRPK1 inhibitor, directly targets its kinase activity, potentially modulating splicing factor phosphorylation and alternative splicing. TBPH, a specific SRPK1 inhibitor, directly modulates SRPK1 activity, potentially influencing splicing factor phosphorylation and alternative splicing. SPSB1 Inhibitor, a reported SRPK1 inhibitor, may directly impact SRPK1 activity, contributing to the regulation of splicing factor phosphorylation and alternative splicing. SPHINX39, a selective SRPK1 inhibitor, directly targets SRPK1, potentially modulating splicing factor phosphorylation and alternative splicing. C16, a specific inhibitor of SRPK1, directly influences SRPK1 activity, potentially impacting splicing factor phosphorylation and alternative splicing. This diverse range of SRPK1 modulators provides researchers with valuable tools to investigate the intricate regulation of alternative splicing processes. The compounds within this class offer potential avenues for understanding SRPK1-mediated cellular functions and their implications for alternative splicing in various biological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SRPIN 340 | 218156-96-8 | sc-394310 | 10 mg | $226.00 | 1 | |
SRPIN340 is a selective SRPK1 and SRPK2 inhibitor that directly modulates the activity of these kinases. By inhibiting SRPK1, SRPIN340 potentially affects the phosphorylation of splicing factors, influencing pre-mRNA splicing and SRPK1-associated cellular processes. | ||||||
Myricetin | 529-44-2 | sc-203147 sc-203147A sc-203147B sc-203147C sc-203147D | 25 mg 100 mg 1 g 25 g 100 g | $97.00 $188.00 $260.00 $510.00 $1022.00 | 3 | |
Myricetin is a natural flavonoid compound that has been reported to inhibit SRPK1 activity. By affecting SRPK1, myricetin may impact the phosphorylation of splicing factors, potentially influencing alternative splicing and cellular processes associated with SRPK1. | ||||||
Tanshinone IIA | 568-72-9 | sc-200932 sc-200932A | 5 mg 25 mg | $88.00 $316.00 | 22 | |
Tanshinone IIA is a natural product that has been reported to inhibit SRPK1 activity. By affecting SRPK1, tanshinone IIA may modulate the phosphorylation of splicing factors, influencing alternative splicing and cellular processes associated with SRPK1. | ||||||
Naphthol AS | 92-77-3 | sc-215536A sc-215536 | 25 g 500 g | $42.00 $162.00 | ||
Naphthol AS-E Phosphate is a selective inhibitor of SRPK1 that directly targets its kinase activity. By inhibiting SRPK1, Naphthol AS-E Phosphate potentially influences the phosphorylation of splicing factors, affecting alternative splicing and cellular processes associated with SRPK1. | ||||||
PKR Inhibitor | 608512-97-6 | sc-204200C sc-204200 sc-204200D sc-204200E sc-204200A sc-204200B | 1 mg 5 mg 10 mg 25 mg 50 mg 100 mg | $65.00 $153.00 $306.00 $612.00 $816.00 $1836.00 | 5 | |
PKR Inhibitor C16 is a specific inhibitor of SRPK1 that directly modulates its kinase activity. By inhibiting SRPK1, C16 potentially impacts the phosphorylation of splicing factors, influencing alternative splicing and cellular processes associated with SRPK1. | ||||||